Shorter radiation improves patient experience but not disease control for intermediate-risk prostate cancer, trial finds

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
News-Medical.Net on MSN

Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the ...